|
시장보고서
상품코드
2054906
매독 검사 시장 : 매독 유형별, 조사 방법별, 검사 시행 장소별, 검체 유형별, 제품 유형별, 기술별, 최종사용자별, 지역별Syphilis Testing Market, By Type of Syphilis, By Test Methodology (Serological Tests and Molecular Diagnostics ), By Location of Testing, By Specimen Type, By Product Format, By Technology, By End User, By Geography |
||||||
매독 검사 시장은 2026년에 13억 3,000만 달러로 추정되고 있으며, 2033년까지 29억 7,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 12.1%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 13억 3,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 12.10% | 2033년 시장 규모 예측 : | 29억 7,000만 달러 |
전 세계 매독 검사 시장은 감염병 진단 업계 전체에서 중요한 부분을 차지하고 있으며, 트레포네마 팔리듐균에 의해 유발되는 성병인 매독의 검출 및 진단에 중점을 두고 있습니다.
매독 검사에는 기존의 혈청학적 검사, 신속 진단 검사, PCR법에 기반한 검사 등 첨단 분자 진단 기술을 포함한 다양한 검사 방법이 포함됩니다. 적절한 항생제 치료로 완치 가능한 감염병임에도 불구하고 전 세계에서, 특히 선진국에서 매독 사례가 다시 증가하고 있으며, 이 시장은 큰 주목을 받고 있습니다.
전 세계 의료 시스템에서는 특히 고위험군, 임산부, 다수의성 파트너를 가진 사람들을 대상으로 포괄적인 선별 검사 프로그램이 시행되고 있으며, 이는 정확하고 신속한 진단 솔루션에 대한 수요를 촉진하고 있습니다. 검사 분야에는 트레포네마 검사와 비트레포네마 검사가 모두 포함되어 있으며, 각각 감염의 서로 다른 단계에서 특정 진단 목적을 수행합니다.
현장 진단 장비는 즉각적인 결과 제공을 통해 매독 진단에 혁신을 가져왔으며, 특히 자원이 제한된 환경이나 응급실 분야에서 유용합니다. 디지털 헬스 기술과 검사실 자동화의 통합을 통해 검사의 효율성과 결과의 정확성이 한층 더 향상되었습니다. 공중보건 관련 노력, 규제 지침, 그리고 성병에 대한 의식의 향상가 계속해서 시장 동향을 주도하고 있으며, 질병의 진행과 감염을 막기 위한 조기 발견과 치료의 중요성이 강조되고 있습니다.
시장 역학
전 세계 매독 검사 시장은 주로 전 세계 매독 발생률의 우려스러운 증가에 힘입어 성장하고 있습니다. 세계보건기구(WHO)는 선진국에서 확진자가 급증하고 있다고 보고하고 있으며, 이로 인해 포괄적인 검사 솔루션에 대한 긴급한 수요가 발생하고 있습니다. 성병 및 선천성 매독 감염을 포함한 장기적인 건강 영향에 대한 인식이 높아짐에 따라 의료 기관에서의 선별 검사 프로그램 확대와 정기적인 검사 프로토콜 도입이 진행되고 있습니다.
성 건강 교육 및 임산부를 대상으로 한 의무적 검사를 추진하는 정부의 노력이 주요 성장 동력이 되고 있는 한편, 신속 진단 검사 및 분자 진단 기술의 발전으로 검사의 정확도가 향상되고 결과가 나오기까지 걸리는 시간이 단축되었습니다. 원격지나 의료 서비스가 미비한 지역에서 현장 진단 장비의 도입이 확대됨에 따라 접근성 문제를 해결하고 시장 성장을 지원하고 있습니다.
그러나 이 시장은 성병에 따른 사회적 편견 등 중대한 제약에 직면해 있습니다. 이러한 편견은 검사 수검률의 저하나 진단 지연으로 이어지는 경우가 적지 않습니다. 또한 첨단 진단 기기의 높은 비용과 개발도상 지역의 의료 인프라 부족은 시장 침투에 있으며, 큰 장벽이 되고 있습니다. 진단 기기 승인과 관련된 규제의 복잡성과 국가마다 다른 검사 지침 또한 시장 관계자들에게 또 다른 과제가 되고 있습니다.
이러한 제약이 있음에도 불구하고 스마트폰을 활용한 진단 솔루션이나 결과 해석에 인공지능(AI)을 통합한 플랫폼 등 혁신적인 검사 기술 개발에는 큰 기회가 존재합니다. 지속적으로 성장하고 있는 원격의료 분야는 원격 검사 상담 및 사후 관리 서비스를 위한 새로운 길을 열어가고 있습니다. 진단 기기 제조업체와 의료 제공자 간의 전략적 제휴에 더해, 정부 및 비정부 기구의성 건강 프로그램에 대한 투자 증가는 특히 매독 유병률이 높고 검사 인프라 구축이 시급한 신흥 경제국에서 시장 성장에 유리한 여건을 조성하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)를 바탕으로 전 세계 매독 검사 시장의 주요 기업을 분석하고 있습니다.
- 이 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 매독 검사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업 및 금융 분석가를 포함한 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 매독 검사 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 매독 검사 시장 : 매독 유형별, 2021-2033년
제5장 세계의 매독 검사 시장 : 검사 방법별, 2021-2033년
제6장 세계의 매독 검사 시장 : 검사 시행 장소별, 2021-2033년
제7장 세계의 매독 검사 시장 : 검체 유형별, 2021-2033년
제8장 세계의 매독 검사 시장 : 제품 형태별, 2021-2033년
제9장 세계의 매독 검사 시장 : 기술별, 2021-2033년
제10장 세계의 매독 검사 시장 : 최종사용자별, 2021-2033년
제11장 세계의 매독 검사 시장 : 지역별, 2021-2033년
제12장 경쟁 구도
제13장 애널리스트의 제안
제14장 참고 문헌 및 조사 방법
KSA 26.06.18Syphilis Testing Market is estimated to be valued at USD 1.33 Bn in 2026 and is expected to reach USD 2.97 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.33 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.10% | 2033 Value Projection: | USD 2.97 Bn |
The global syphilis testing market represents a critical segment within the broader infectious disease diagnostics industry, focusing on the detection and diagnosis of syphilis, a sexually transmitted infection caused by the bacterium Treponema pallidum.
Syphilis testing encompasses various diagnostic methodologies including traditional serological tests, rapid diagnostic tests, and advanced molecular diagnostic techniques such as PCR-based assays. The market has gained significant attention due to the resurgence of syphilis cases worldwide, particularly in developed countries, despite being a curable infection with appropriate antibiotic treatment.
Healthcare systems globally are implementing comprehensive screening programs, especially for high-risk populations, pregnant women, and individuals with multiple sexual partners, driving the demand for accurate and rapid diagnostic solutions. The testing landscape includes both treponemal and non-treponemal tests, each serving specific diagnostic purposes in different stages of infection.
Point-of-care testing devices have revolutionized syphilis diagnosis by providing immediate results, particularly beneficial in resource-limited settings and emergency departments. The integration of digital health technologies and laboratory automation has further enhanced testing efficiency and result accuracy. Public health initiatives, regulatory guidelines, and increasing awareness about sexually transmitted infections continue to shape the market dynamics, emphasizing the importance of early detection and treatment to prevent disease progression and transmission.
Market Dynamics
The global syphilis testing market is primarily driven by the alarming rise in syphilis incidence rates worldwide, with the World Health Organization reporting significant increases in developed nations, creating urgent demand for comprehensive testing solutions. Growing awareness about sexually transmitted infections and their long-term health consequences, including congenital syphilis transmission, has led to expanded screening programs and routine testing protocols in healthcare facilities.
Government initiatives promoting sexual health education and mandatory testing for pregnant women serve as key growth catalysts, while technological advancements in rapid diagnostic tests and molecular diagnostics have improved testing accuracy and reduced turnaround times. The increasing adoption of point-of-care testing devices in remote and underserved areas addresses accessibility challenges and supports market expansion.
However, the market faces significant restraints including social stigma associated with sexually transmitted infections, which often leads to reduced testing compliance and delayed diagnosis. High costs of advanced diagnostic equipment and limited healthcare infrastructure in developing regions pose substantial barriers to market penetration. Regulatory complexities surrounding diagnostic device approvals and varying testing guidelines across different countries create additional challenges for market players.
Despite these constraints, substantial opportunities exist in the development of innovative testing technologies, including smartphone-based diagnostic solutions and artificial intelligence-integrated platforms for result interpretation. The expanding telemedicine sector presents new avenues for remote testing consultation and follow-up services. Strategic partnerships between diagnostic companies and healthcare providers, along with increasing investments in sexual health programs by government and non-government organizations, create favorable conditions for market growth, particularly in emerging economies where syphilis prevalence remains high and testing infrastructure requires significant development.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global syphilis testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, BD (Becton, Dickinson and Company), Siemens Healthineers, bioMerieux, Hologic, Cepheid, Bio-Rad Laboratories, Thermo Fisher Scientific, Ortho Clinical Diagnostics, QuidelOrtho, Trinity Biotech, SD Biosensor, Healgen Scientific, and Mologic
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global syphilis testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global syphilis testing market
Market Segmentation
- Type of Syphilis Insights (Revenue, USD Bn, 2021 - 2033)
- Primary and Secondary Syphilis
- Latent and Tertiary Syphilis
- Test Methodology Insights (Revenue, USD Bn, 2021 - 2033)
- Serological Tests
- Non-Treponemal Tests (e.g., RPR, VDRL)
- Treponemal Tests (e.g., TPHA, FTA-ABS)
- Molecular Diagnostics
- Nucleic Acid Amplification Tests (NAATs)
- Polymerase Chain Reaction (PCR)
- Location of Testing Insights (Revenue, USD Bn, 2021 - 2033)
- Laboratory Testing
- Point-of-Care (POC) Testing
- Specimen Type Insights (Revenue, USD Bn, 2021 - 2033)
- Serum/Plasma
- Whole Blood
- Oral Fluid
- Dried Blood Spot (DBS)
- Product Format Insights (Revenue, USD Bn, 2021 - 2033)
- Diagnostic Kits
- Reagents and Consumables
- Instruments and Analyzers
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chemiluminescent Immunoassay (CLIA)
- Lateral Flow Assays (LFA)
- Rapid Plasma Reagin (RPR)
- Treponemal Particle Agglutination (TPPA)
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Diagnostic Laboratories
- Point-of-Care (POC) Settings
- Home Care/Self-Testing
- Others (Academic and Research Institutes)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Roche Diagnostics
- Abbott Laboratories
- BD (Becton, Dickinson and Company)
- Siemens Healthineers
- bioMerieux
- Hologic
- Cepheid
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Ortho Clinical Diagnostics
- QuidelOrtho
- Trinity Biotech
- SD Biosensor
- Healgen Scientific
- Mologic
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Syphilis Testing Market, By Type of Syphilis
- Global Syphilis Testing Market, By Test Methodology
- Global Syphilis Testing Market, By Location of Testing
- Global Syphilis Testing Market, By Specimen Type
- Global Syphilis Testing Market, By Product Format
- Global Syphilis Testing Market, By Technology
- Global Syphilis Testing Market, By End User
- Global Syphilis Testing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Syphilis Testing Market, By Type of Syphilis, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Primary and Secondary Syphilis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Latent and Tertiary Syphilis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Syphilis Testing Market, By Test Methodology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Serological Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Non-Treponemal Tests (e.g., RPR, VDRL)
- Treponemal Tests (e.g., TPHA, FTA-ABS)
- Molecular Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Nucleic Acid Amplification Tests (NAATs)
- Polymerase Chain Reaction (PCR)
6. Global Syphilis Testing Market, By Location of Testing, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Laboratory Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Point-of-Care (POC) Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Syphilis Testing Market, By Specimen Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Serum/Plasma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Whole Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Oral Fluid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Dried Blood Spot (DBS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Syphilis Testing Market, By Product Format, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Diagnostic Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Reagents and Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Instruments and Analyzers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Syphilis Testing Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chemiluminescent Immunoassay (CLIA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Lateral Flow Assays (LFA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Rapid Plasma Reagin (RPR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Treponemal Particle Agglutination (TPPA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Syphilis Testing Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Point-of-Care (POC) Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Care/Self-Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Academic and Research Institutes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Syphilis Testing Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type of Syphilis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Methodology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Location of Testing, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type of Syphilis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Methodology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Location of Testing, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type of Syphilis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Methodology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Location of Testing, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type of Syphilis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Methodology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Location of Testing, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type of Syphilis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Methodology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Location of Testing, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type of Syphilis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Methodology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Location of Testing, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BD (Becton, Dickinson and Company)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- bioMerieux
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hologic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cepheid
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ortho Clinical Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QuidelOrtho
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Trinity Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SD Biosensor
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Healgen Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mologic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
